Management of systemic lupus erythematosus during pregnancy: challenges and solutions
- PMID: 28331377
- PMCID: PMC5354538
- DOI: 10.2147/OARRR.S87828
Management of systemic lupus erythematosus during pregnancy: challenges and solutions
Abstract
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease predominantly affecting women, particularly those of childbearing age. SLE provides challenges in the prepregnancy, antenatal, intrapartum, and postpartum periods for these women, and for the medical, obstetric, and midwifery teams who provide their care. As with many medical conditions in pregnancy, the best maternal and fetal-neonatal outcomes are obtained with a planned pregnancy and a cohesive multidisciplinary approach. Effective prepregnancy risk assessment and counseling includes exploration of factors for poor pregnancy outcome, discussion of risks, and appropriate planning for pregnancy, with consideration of discussion of relative contraindications to pregnancy. In pregnancy, early referral for hospital-coordinated care, involvement of obstetricians and rheumatologists (and other specialists as required), an individual management plan, regular reviews, and early recognition of flares and complications are all important. Women are at risk of lupus flares, worsening renal impairment, onset of or worsening hypertension, preeclampsia, and/or venous thromboembolism, and miscarriage, intrauterine growth restriction, preterm delivery, and/or neonatal lupus syndrome (congenital heart block or neonatal lupus erythematosus). A cesarean section may be required in certain obstetric contexts (such as urgent preterm delivery for maternal and/or fetal well-being), but vaginal birth should be the aim for the majority of women. Postnatally, an ongoing individual management plan remains important, with neonatal management where necessary and rheumatology followup. This article explores the challenges at each stage of pregnancy, discusses the effect of SLE on pregnancy and vice versa, and reviews antirheumatic medications with the latest guidance about their use and safety in pregnancy. Such information is required to effectively and safely manage each stage of pregnancy in women with SLE.
Keywords: management of pregnancy; medication; neonatal lupus; preconception counseling; pregnancy complications; systemic lupus erythematosus.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Similar articles
-
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.Am J Obstet Gynecol. 2023 Mar;228(3):B41-B60. doi: 10.1016/j.ajog.2022.09.001. Epub 2022 Sep 6. Am J Obstet Gynecol. 2023. PMID: 36084704
-
Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.Lupus. 2019 Oct;28(12):1417-1426. doi: 10.1177/0961203319877247. Epub 2019 Sep 24. Lupus. 2019. PMID: 31551036
-
Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support.J Clin Med. 2024 Jun 13;13(12):3454. doi: 10.3390/jcm13123454. J Clin Med. 2024. PMID: 38929983 Free PMC article. Review.
-
Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome.Best Pract Res Clin Rheumatol. 2017 Jun;31(3):397-414. doi: 10.1016/j.berh.2017.09.011. Epub 2017 Oct 11. Best Pract Res Clin Rheumatol. 2017. PMID: 29224680 Review.
-
Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.Immunol Res. 2017 Apr;65(2):487-494. doi: 10.1007/s12026-016-8888-5. Immunol Res. 2017. PMID: 28138914
Cited by
-
Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.NPJ Genom Med. 2022 Sep 14;7(1):55. doi: 10.1038/s41525-022-00325-w. NPJ Genom Med. 2022. PMID: 36100603 Free PMC article.
-
Clinical efficacy of plasma exchange in systemic lupus erythematosus during pregnancy.Immun Inflamm Dis. 2023 Oct;11(10):e1041. doi: 10.1002/iid3.1041. Immun Inflamm Dis. 2023. PMID: 37904711 Free PMC article.
-
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports.Ann Rheum Dis. 2023 Feb;82(2):217-225. doi: 10.1136/ard-2022-222505. Epub 2022 Oct 5. Ann Rheum Dis. 2023. PMID: 36198440 Free PMC article.
-
B cells: roles in physiology and pathology of pregnancy.Front Immunol. 2024 Oct 7;15:1456171. doi: 10.3389/fimmu.2024.1456171. eCollection 2024. Front Immunol. 2024. PMID: 39434884 Free PMC article. Review.
-
Pernicious placenta previa/placenta percreta complicating active systemic lupus erythematosus resulting in postoperative artery thrombosis.J Int Med Res. 2019 Dec;47(12):6365-6373. doi: 10.1177/0300060519886991. Epub 2019 Nov 27. J Int Med Res. 2019. PMID: 31773999 Free PMC article.
References
-
- Rahman A, Isenberg D. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929–939. - PubMed
-
- Dall’Era M. Chapter 21 Systemic lupus erythematosus. In: Imboden JB, Stone JH, Hellmann DB, editors. Current rheumatology diagnosis & treatment. 3 ed. USA: McGraw-Hill; 2013.
-
- Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002;16(5):847–858. - PubMed
-
- Gladman D, Urowitz M. Chapter 69. Prognosis, Mortality, and Morbidity in Systemic Lupus Erythematosus. In: Wallace D, Hahn B, editors. Dubois’ Lupus Erythematosus. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 1333–1353.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials